C(2)-METHYLATION ABOLISHES DA1 DOPAMINE AGONIST ACTIVITY OF 2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE (6,7-ADTN) - STERIC INTOLERANCE BY THE RECEPTOR

被引：16

作者：

NICHOLS, DE ^{[1
]}

JACOB, JN ^{[1
]}

HOFFMAN, AJ ^{[1
]}

KOHLI, JD ^{[1
]}

GLOCK, D ^{[1
]}

机构：

[1] UNIV CHICAGO,COMM CLIN PHARMACOL,CHICAGO,IL 60637

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1984年 / 27卷 / 12期

关键词：

D O I：

10.1021/jm00378a029

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1701 / 1705

页数：5

共 50 条

[31] Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines; Oxidation and neurotoxicity
Naoi, M
Maruyama, W
Dostert, P
CURRENT NEUROCHEMICAL AND PHARMACOLOGICAL ASPECTS OF BIOGENIC AMINES, 1995, 106 : 227 - 239
[32] Regioselectivity of the bromination of 1-oxo-1,2,3,4-tetrahydronaphthalene and 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydronaphthalene, and thiabiscyclanones synthesis on their basis
Pankratov, AN
Fedotova, OV
Barabanova, AV
Alyonkina, TV
Eliseev, YY
JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2004, 69 (06) : 421 - 429
[33] STRIATAL BINDING OF 2-AMINO-6,7-[H-3]DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE TO 2 DOPAMINERGIC SITES DISTINGUISHED BY THEIR LOW AND HIGH-AFFINITY FOR NEUROLEPTICS
LIST, SJ
WREGGETT, KA
SEEMAN, P
JOURNAL OF NEUROSCIENCE, 1982, 2 (07): : 895 - 906
[34] BINDING OF [H-3]AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE TO RAT STRIATAL MEMBRANES - EFFECTS OF PURINE NUCLEOTIDES AND ULTRAVIOLET-IRRADIATION
ZAHNISER, NR
HEIDENREICH, KA
MOLINOFF, PB
MOLECULAR PHARMACOLOGY, 1981, 19 (03) : 372 - 378
[35] ANALYSIS OF SYMPATHOMIMETIC ACTIVITY OF 6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISO-QUINOLINE (TIQ)
SIMPSON, LL
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1975, 192 (02): : 365 - 371
[36] DOPAMINE RECEPTOR CHARACTERIZATION - AGONIST REQUIREMENTS FOR BINDING USING [H-3]-6,7,-DIHYDROXY 1,2,3,4-TETRAHYDRONAPTHALENE (ADTN) - POTENTIAL SPECIFIC DOPAMINE RECEPTOR LIGAND
ABEL, MS
CLEMENTCORMIER, Y
PHARMACOLOGIST, 1978, 20 (03): : 241 - 241
[37] DOPAMINE RECEPTOR AGONISTS .1. SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 4-ARYL-SUBSTITUTED ANALOGS OF 6,7-DIHYDROXY-2-AMINOTETRALIN (6,7-ADTN) AND RELATED INDANE COMPOUNDS
BERTOLINI, G
VECCHIETTI, V
MABILIA, M
NORCINI, G
RESTELLI, A
SANTANGELO, F
VILLA, AM
CASAGRANDE, C
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1992, 27 (07) : 663 - 672
[38] 6,7-DIHYDROXY-3-CHROMANAMINE - SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF AN OXYGEN ISOSTERE OF THE DOPAMINE AGONIST 6,7-DIHYDROXY-2-AMINOTETRALIN
HORN, AS
KAPTEIN, B
MULDER, TBA
DEVRIES, JB
WYNBERG, H
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (10) : 1340 - 1343
[39] INHIBITION OF COMT ACTIVITY BY 1-(3,4,5-TRIMETHOXYBENZYL)-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE AND 1-(3,5-DIMETHOXY-4-HYDROXYBENZYL)-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE IN VITRO
HATTORI, K
MATSUURA, M
SHIMAMOTO, K
JAPANESE JOURNAL OF PHARMACOLOGY, 1969, 19 (02): : 287 - +
[40] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 2-SUBSTITUTED AND 4-SUBSTITUTED 6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINES
SMISSMAN, EE
REID, JR
WALSH, DA
BORCHARDT, RT
JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (01) : 127 - 131

← 1 2 3 4 5 →